Our Latest News

  • $5.5 million NIH grant supports new tests to diagnose dementias earlier and easier

    Researchers at Case Western Reserve University School of Medicine seek to optimize emerging methods of diagnosing two common neurodegenerative diseases—dementia with Lewy bodies and Parkinson’s disease dementia—which affect 1.4 million in the United States

    With a $5.5 million, five-year award from the National Institutes of Health (NIH), researchers at Case Western Reserve University will seek to systemize new diagnostic tests for dementia with Lewy bodies and Parkinson’s disease dementia—together the second-most-common dementias after Alzheimer’s disease.

  • Health Care Cleveland—COVID, 2020 and Beyond

    A Series of Health Care Forums Addressing Today’s Most Demanding Global Health Care Issues 

    The first presidential debate leading up to the election in November was held on September 29 at the Health Education Campus, where candidates addressed demanding health care issues in addition to other critical topics. Cleveland is the nation’s leader in health care research and delivery, innovation, biotechnology, medical and interprofessional education, and health care reform.

  • Congratulations to the Physician Assistant Class of 2020!

    We salute 34 students who graduated from the School of Medicine's physician assistant (PA) Class of 2020 on Sunday, August 30. Like many other firsts we’ve experienced this year, this was the first PA class to graduate virtually.  
  • New study finds hydroxychloroquine ineffective as preventive antiviral against COVID-19

    Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population.
  • Scientists work to freeze-dry synthetic platelets

    A Case Western Reserve University scientist, who has for more than a decade pioneered research into synthetic platelet substitutes, has been awarded a $3.8 million grant by the U.S. Department of Defense (DOD) to develop freeze-dried artificial platelets that can treat bleeding in wounded soldiers in the battlefield before they can be taken to a hospital.
  • A measured approach

    ​Physicians and nurses rush into a hospital room when a patient is in crisis or near death. It’s both instinctive and engrained by practice. But amid the pandemic, there’s no dashing in. Instead there’s a methodical donning of personal protective equipment (PPE) to avoid contamination and further spread of the coronavirus—“and then you go into a room,” said Edward Warren, MD (MED ’87), division director of pulmonary/critical care and sleep medicine at The MetroHealth System in Cleveland and an associate professor of medicine at Case Western Reserve. ​
  • School of Medicine’s Physician Assistant program achieves maximum accreditation status

    Just four years after its first class of students matriculated in 2016, Case Western Reserve University School of Medicine’s Physician Assistant (PA) Program has achieved a new milestone: The program has been granted accreditation-continued status by the Accreditation Review Commission on Education for the Physician Assistant, Inc. (ARC-PA), the highest accreditation status a PA program can receive. 
  • St. Baldrick’s Foundation awards grants to Case Western Reserve for pediatric cancer research

    Cancer researchers Alex Huang, Reshmi Parameswaran and Yamilet Huerta have been awarded $315,000 in grants from the St. Baldrick’s Foundation to conduct research of new immunotherapy treatments for pediatric cancers.
  • College of Arts and Sciences, School of Medicine collaborate to offer new undergraduate neuroscience major

    Case Western Reserve University will offer a new bachelor of science degree in neuroscience beginning fall semester 2020. Developed jointly by the Department of Biology in the College of Arts and Sciences and the Department of Neurosciences in the School of Medicine, the undergraduate program is highly collaborative and multidisciplinary.
  • Our newest medical students receive their white coats

    On a perfect Sunday morning, 216 first-year medical students participated in the School of Medicine’s White Coat Ceremony, a rite of passage officially welcoming them into the community of healers. The physician’s white coat is a powerful symbol of the profession, and the ceremony launched these students at the beginning of their medical education—because becoming a doctor is not just a job or career—it is a life choice.

  • Biomedical engineer Pallavi Tiwari named ‘Women in STEM2D Scholar’

    Pallavi Tiwari’s impact on brain cancer research was recognized in June when she was selected as one of six winners of the third annual Johnson & Johnson Women in STEM2D (WiSTEM2D) Scholars Award. Each recipient, representing each of the STEM2D disciplines—science, technology, engineering, math, manufacturing and design—will receive a $150,000 grant and three years of mentorship.
  • Case Western Reserve University-led team develops new approach to treat certain neurological diseases

    A team led by Case Western Reserve University medical researchers has developed a potential treatment method for Pelizaeus-Merzbacher disease (PMD), a fatal neurological disorder that produces severe movement, motor and cognitive dysfunction in children. It results from genetic mutations that prevent the body from properly making myelin, the protective insulation around nerve cells.
  • Stan Gerson becomes School of Medicine's interim dean and interim senior VP for medical affairs

    Stan Gerson, Director of the Case Comprehensive Cancer Center (Case CCC), has become interim dean for the School of Medicine and interim senior vice president for medical affairs, effective July 1, 2020.
  • Pamela B. Davis returns to faculty after 13 years as School of Medicine dean

    After a 13-year tenure that saw the School of Medicine swing from multi-million-dollar deficits to record-breaking fundraising and research awards, Pamela B. Davis will return to the faculty full-time as of July 1.
  • Anesthesiology’s James D. Reynolds awarded COVID-19 Rapid Response Initiative grant from Harrington Discovery Institute

    When a research project over 15 years in the making resulted in a drug that improved pulmonary function and oxygen delivery, researcher James D. Reynolds thought the drug could also help COVID-19 patients with severely compromised lung and heart function. Reynolds, Professor of Anesthesiology & Perioperative Medicine, was recently awarded a grant from the Harrington Discovery Institute’s (HDI) COVID-19 Rapid Response Initiative to answer that very question.